Lung Transplantation

Treatment for Silicosis

Effectiveness
50%
Safety Score
25%
Clinical Trials
2
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanideโ˜ ๏ธ
Meth๐Ÿ’€
Cigarettes๐Ÿšฌ
Chemoโ˜ข๏ธ
Alcohol๐Ÿบ
Morphine๐Ÿ’Š
Antibiotics๐Ÿ’‰
Tylenol๐Ÿ’Š
Exercise๐Ÿƒ
Water๐Ÿ’ง
25
DangerousModerateSafe
Treatment Details
Time to Effect
3-6 months post-surgery
Treatment Duration
lifetime
Evidence Quality
HIGH
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30,000
Monitoring:$15,000
Side Effect Mgmt:$10,000
Total Annual:$55,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
ICER
$250,000/QALY
QALYs Gained
3
Outcome-Based Costs
Cost per Responder
$91,667
Lung Transplantation Outcomes

for Silicosis

Efficacy Outcomes
Overall Effectiveness
+50%
Response Rate
+60%
Common Side Effects
Rejection
+25%
Infection
+40%
Kidney dysfunction
+25%
Cancer
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Lung Transplantation in Silicosis

Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study

NCT06922916NOT YET RECRUITING
View Study
250 participants
OBSERVATIONAL
Hangzhou, China
Started: Apr 22, 2025
Completed Clinical Trials
1 completed trial for Lung Transplantation in Silicosis

Safety of Stem Cells Intrabronchial Instillation for Silicosis

NCT01239862COMPLETEDPHASE1
View Study
5 participants
INTERVENTIONAL
Rio de Janeiro, Brazil
Started: Aug 1, 2009